Expression of Wnt5a and its receptor Fzd2 is changed in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 7, 2013, Pages 1245-1260

  Li, Xiaojin ^a   Guan, Yingjun ^a   Chen, Yanchun ^a   Zhang, Caixia ^a   Shi, Caixing ^a   Zhou, Fenghua ^a   Yu, Li ^a   Juan, Juan ^a   Wang, Xin ^b  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ALS; Astrocyte; Fzd2; NSC34; Wnt signaling pathway; Wnt5a

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FRIZZLED PROTEIN; FZD2 PROTEIN, MOUSE; SUPEROXIDE DISMUTASE; WNT PROTEIN; WNT5A PROTEIN, MOUSE;

ALS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; ARTICLE; ASTROCYTE; CELL CULTURE; DISEASE MODEL; FZD2; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MOUSE; NSC34; SPINAL CORD; TIME; TRANSGENIC MOUSE; WNT SIGNALING PATHWAY; WNT5A;

ALS; ASTROCYTE; FZD2; NSC34; WNT SIGNALING PATHWAY; WNT5A;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FRIZZLED RECEPTORS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, TRANSGENIC; SPINAL CORD; SUPEROXIDE DISMUTASE; TIME FACTORS; TRANSFECTION; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84882938887     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Corcia P, Gordon PH. Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole. Ther Clin Risk Manag 2012; 8: 359-366.
2. Sakowski SA, Lunn JS, Busta AS, Oh SS, Zamora-Berridi G, Palmer M, Rosenberg AA, Philip SG, Dowling JJ, Feldman EL. Neuromuscular effects of G93A-SOD1 expression in zebrafish. Mol Neurodegener 2012; 7: 44.
3. Borges-Alvarez M, Benavente F, Barbosa J, Sanz-Nebot V. Separation and characterization of superoxide dismutase 1 (SOD-1) from human erythrocytes by capillary electrophoresis time-of-flight mass spectrometry. Electropho-resis 2012; 33: 2561-2569.
4. Chen Y, Guan Y, Zhang Z, Liu H, Wang S, Yu L, Wu X, Wang X. Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice. Neurol Res 2012; 34: 390-399.
5. Choi HJ, Park H, Lee HW, Kwon YG. The Wnt pathway and the roles for its antagonists, DKKS, in angiogenesis. IUBMB Life 2012; 64: 724-731.
6. Chen Y, Guan Y, Liu H, Wu X, Yu L, Wang S, Zhao C, Du H, Wang X. Activation of the Wnt/ß-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochem Biophys Res Commun 2012; 20: 397-403.
7. Willert K, Nusse R. Wnt proteins. Cold Spring Harb Perspect Biol 2012; 4: a007864.
8. Nusse R, Varmns HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. J Cell 1982; 31: 99-109.
9. Parr BA, Shea MJ, Vassileva G, McMahon AP. Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. Development 1993; 119: 247-261.
10. Hsieh JC, Rattner A, Smallwood PM, Nathans J. Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate Wnt protein. Proc Natl Acad Sci U S A 1999; 96: 3546-3551.
11. Dann CE, Hsieh JC, Rattner A, Sharma D, Nathans J, Leahy DJ. Insights into Wnt binding and signaling from the structures of two Frizzled cysteine-rich domains. Nature 2001; 412: 86-90.
12. Sato A, Yamamoto H, Sakane H, Koyama H, Kikuchi A. Wnt5a regulates distinct signaling pathways by binding to Frizzled2. The EMBO Journal 2010; 29: 41-54.
13. van Amerongen R, Fuerer C, Mizutani M, Nusse R. Wnt5a can both activate and repress Wnt/ß-catenin signaling during mouse embryonic development. Dev Biol 2012; 369: 101-114.
14. Mikeis AJ, Nusse R. Purified Wnt5a protein activates or inhibits ß-cateinin-TCF signaling depending on receptor context. J PLoS Biol 2006; 4: e115.
15. Cohen ED, Miller MF, Wang Z, Moon RT, Morrisey EE. Wnt5a and Wnt11 are essential for second heart field progenitor development. Development 2012; 139: 1931-1940.
16. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10. J Oncol Rep 2005; 14: 925-932.
17. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. J Clin Cancer Res 2005; 11: 8606-8614.
18. Wang HY, Liu T, Malbon CC. Structure-function analysis of Frizzleds. Cell Signal 2006; 18: 934-941.
19. Poletti A, Cattaneo E, Taroni F. The neurotoxicity of mutant proteins 20 years after the discovery of the first mutant gene involved in neurodegeneration. Foreword Prog Neurobiol 2012; 97: 53.
20. Rowitch DH. Glial specification in the vertebrate neural tube. Nat Rev Neurosci 2004; 5: 409-419.
21. Doetsch F. The glial identity of neural stem cells. Nat Neurosci 2003; 6: 1127-1134.
22. Vargas MR, Johnson JA. Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes. J Neurotherapeutics 2010; 7: 471-481.
23. Henriques A, Pitzer C, Schneider A. Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand? Front Neurosci 2010; 4: 32.
24. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. J Nat Neurosc 2007; 10: 615-622.
25. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 2007; 10: 608-614.
26. Dupuis L, Pehar M, Cassina P, Rene F, Castellanos R, Rouaux C, Gandelman M, Dimou L, Schwab ME, Loeffler JP, Barbeito L, Gonzalez de Aguilar JL. Nogo receptor antagonizes p75NTR-dependent motor neuron death. J Proc Natl Acad Sci U S A 2008; 105: 740-745.